This inventor holds 2 USPTO granted patents. Top assignees: New York University, The General Hospital Corporation. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2013-2015
Title: Innovations by Jae Wook Lee in Obesity Treatment and HIV Inhibition
Introduction
Jae Wook Lee is an accomplished inventor based in San Diego, CA. He has made significant contributions to the fields of obesity treatment and HIV research. With a total of 2 patents, his work focuses on innovative methods and compositions that address critical health issues.
Latest Patents
Jae Wook Lee's latest patents include compositions and methods for treating obesity and obesity-related disorders, as well as for inhibiting the infectivity of human immunodeficiency virus (HIV). His inventions involve administering oleuropein and its derivatives, which are known for their potential health benefits. The methods also include screening and diagnosing subjects predisposed to obesity by measuring the expression profiles of specific adipogenic genes. This innovative approach aims to provide effective treatments for individuals suffering from obesity and related disorders.
Career Highlights
Throughout his career, Jae Wook Lee has worked with prestigious institutions such as New York University and The General Hospital Corporation. His research has contributed to advancements in pharmaceutical compositions and methods that target significant health challenges.
Collaborations
Jae Wook Lee has collaborated with notable colleagues, including Sylvia Lee-Huang and Dawei Zhang. These partnerships have enhanced the scope and impact of his research in the medical field.
Conclusion
Jae Wook Lee's innovative work in treating obesity and inhibiting HIV showcases his dedication to improving health outcomes. His contributions through patents and collaborations highlight the importance of research in addressing pressing health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile